SPOTLIGHT -
Sales presentation for BD Ophthalmics
ARVO 2024: Detection of glaucoma with a novel widefield imaging device combined with OCT
Claris Bio's journey toward treating neurotrophic keratitis
ARVO 2024: Abnormal subendothelial matrix exacerbates choroidal endothelial cell death in early AMD
(EyePod) From idea to impact: Navigating ophthalmic innovation
ARVO 2024: Exploratory analysis of pivotal phase 3 trials, YOSEMITE and RHINE, for vabysmo in DME
Ocugen completes dosing in second cohort of GARDian clinical trial for Stargardt disease